Catalyst Intel:
Governor Newsom has publicly stated his opposition to the "billionaire tax," which is a significant negative catalyst. A governor's opposition can heavily influence public opinion and mobilize resources against a ballot initiative. Additionally, the news indicates that tech giants are spending heavily to influence California politics, suggesting strong financial opposition is likely for such a tax.
Found: Mar 27, 2026 11:54 PM
Legal Reasoning:
Market A resolves to 'Yes' if a specific ballot initiative is certified by June 25, 2026, for the November 3, 2026 California election. Market B resolves to 'Yes' if such an initiative 'passes' voter approval. For Market B to resolve to 'Yes', the initiative must first be certified and appear on the ballot. Market A imposes a stricter, earlier deadline (June 25, 2026) for this certification compared to the implicit requirements for Market B. If an initiative is certified after June 25, 2026, but still makes it onto the November 3, 2026 ballot and passes voter approval, Market B would resolve to 'Yes' while Market A would resolve to 'No'. This scenario indicates that Market A's conditions are stricter or have an earlier deadline for a prerequisite event compared to Market B's resolution condition, fitting the definition of A_SUBSET_OF_B, despite the parenthetical clause in the definition not being strictly met due to the possibility of certification by June 25 but failure to pass voter approval.
Found: Mar 27, 2026 11:54 PM
Filibuster change this year?
Filibuster weakened before 2027
[Before 2027]
+23.0%
Cost: $0.770
BUY [NO] on Polymarket ($0.56) AND BUY [YES] on Kalshi ($0.21) (SUBSET FREE-ROLL)
Catalyst Intel:
Multiple news snippets indicate strong pressure from former President Donald Trump and his allies to weaken or eliminate the filibuster. Phrases like 'pressures GOP to scrap filibuster,' 'eye nuking it,' and 'threatens to end filibuster' demonstrate a clear intent and active push to remove this procedural obstacle, particularly to pass legislation like the SAVE America Act. Given Trump's potential influence and the explicit desire to change the filibuster, this constitutes a massive catalyst for it to be weakened before 2027.
Found: Mar 27, 2026 10:36 AM
Legal Reasoning:
Market A requires a specific event: a cloture motion passing with fewer than three-fifths of Senators on a legislative matter. For such a motion to pass, the filibuster threshold must first have been lowered for the legislative process. Market B is broader, resolving to "Yes" if the filibuster threshold is lowered in any capacity (e.g., for legislative matters, confirmations, or both) and does not require an instance of a cloture motion passing. If Market A resolves "Yes," it inherently means the filibuster threshold was lowered, making Market B also resolve "Yes." However, Market B could resolve "Yes" without Market A resolving "Yes" if: 1) the threshold is lowered only for confirmations (which Market A explicitly excludes), or 2) the threshold is lowered for legislative matters, but no actual cloture motion passes under the new threshold before the deadline. Therefore, Market A's conditions are stricter than Market B's.
Found: Mar 27, 2026 10:36 AM
IPOs
Who will IPO before 2027?
[Anysphere (Cursor)]
+21.0%
Cost: $0.790
BUY [NO] on Polymarket ($0.69) AND BUY [YES] on Kalshi ($0.1)
Catalyst Intel:
Multiple news snippets indicate a strong likelihood of several high-profile companies, particularly in the AI sector, going public before 2027. OpenAI is strongly hinted for a 2026 IPO, supported by SoftBank's $40B loan maturing in March 2027. Anthropic is reported to be preparing for an IPO as early as October this year, with major banks involved. Kailera Therapeutics has already filed for a U.S. IPO. SpaceX is also mentioned with 'IPO buzz'. This collective information points to a significant increase in IPO activity before the 2027 deadline.
Found: Mar 28, 2026 1:19 AM
Legal Reasoning:
Both markets resolve to "Yes" if Anysphere (Cursor) completes an IPO by December 31, 2026. Market A's deadline of "December 31, 2026, 11:59 PM ET" is equivalent to Market B's "before Jan 1, 2027". While Market A explicitly mentions negative resolution for mergers/acquisitions/cessation, it is a standard assumption that an IPO for the named entity would not occur if it were acquired or ceased to exist, meaning Market B would also implicitly resolve "No" in such scenarios. The conditions and timeframes are virtually identical.
Found: Mar 28, 2026 1:19 AM
World leaders out this year?
Will Benjamin Netanyahu leave Prime Minister of Israel before Jan 1, 2027?
[:: Prime Minister of Israel]
+16.0%
Cost: $0.840
BUY [NO] on Polymarket ($0.52) AND BUY [YES] on Kalshi ($0.32)
Catalyst Intel:
There are multiple significant catalysts. A senior US official (JD Vance) had a 'tense call' with Benjamin Netanyahu, criticizing his 'overconfidence' and 'selling easy Iran war to Trump,' stating that Netanyahu's predictions 'had not materialized.' This indicates a major strain in the crucial US-Israel relationship and a loss of confidence from a key ally regarding Netanyahu's handling of a major conflict. Additionally, a warning from Zamir about a 'shortage of soldiers' harming military readiness, sent to Netanyahu, highlights internal military challenges. The release of 'The Bibi Files,' a critical documentary, further adds to potential domestic pressure. These factors combined suggest significant pressure on Netanyahu's leadership, making it more likely he will leave office.
Found: Mar 28, 2026 3:48 AM
Legal Reasoning:
Both markets resolve to "Yes" if Benjamin Netanyahu announces resignation, steps down, or is removed from the position of Prime Minister of Israel. The deadline for both markets is identical: Market A specifies "by December 31, 2026, 11:59 PM ET", while Market B states "before Jan 1, 2027", which covers the exact same period. The conditions and timeframes are virtually identical, meaning if one market resolves to "Yes", the other will as well, and vice-versa. There are no stricter conditions, earlier deadlines, or conflicting rules that would lead to a different resolution.
Found: Mar 28, 2026 3:48 AM
IPOs
Who will IPO before 2027?
[Databricks]
+15.0%
Cost: $0.850
BUY [NO] on Polymarket ($0.62) AND BUY [YES] on Kalshi ($0.23)
Catalyst Intel:
Kailera Therapeutics has filed for a U.S. IPO, indicating an imminent public offering well before 2027. Anthropic is reportedly planning an IPO as early as October, with talks already underway with major banks, strongly suggesting an IPO before 2027. OpenAI has strong signals for a 2026 IPO, supported by SoftBank's $40B loan maturing in March 2027, providing flexibility for a listing within that timeframe. Visma, while delayed, is still expected to IPO next year, placing it before 2027. These events collectively represent massive catalysts, confirming that multiple significant companies are on track to IPO before 2027.
Found: Mar 28, 2026 1:19 AM
Legal Reasoning:
Both markets concern an IPO by Databricks with identical deadlines (Market A: 'by December 31, 2026, 11:59 PM ET'; Market B: 'before Jan 1, 2027'). Market B's confirmation source ('Databricks confirms an IPO') is a subset of Market A's ('official company announcements or credible news sources'). In practice, if an IPO occurs and is confirmed by official company announcements or credible news sources, Databricks itself would almost certainly have confirmed it. The 'No' conditions in Market A are standard implicit understandings for IPO markets and do not create a conflict or a scenario where one market resolves 'Yes' and the other 'No' for the same event. Therefore, the conditions and timeframes are virtually identical.
Found: Mar 28, 2026 1:19 AM
Texas Senate Election
Will GOP Nominee be Ken Paxton AND General Election Winner be Republican for Jan 2027?
[Paxton beats Talarico]
+14.0%
Cost: $0.860
BUY [NO] on Polymarket ($0.47) AND BUY [YES] on Kalshi ($0.39)
Catalyst Intel:
No news was provided to evaluate for a catalyst. Therefore, no catalyst can be identified for the market 'Will GOP Nominee be Ken Paxton AND General Election Winner be Republican for Jan 2027?'.
Found: Mar 27, 2026 9:24 PM
Legal Reasoning:
For Market A to resolve to 'Paxton beats Talarico', Ken Paxton must be the Republican nominee and win the 2026 Texas U.S. Senate election. This outcome directly matches the conditions for Market B to resolve 'Yes' (GOP Nominee: Ken Paxton, General Election Winner: Republican). The timeframe for a 2026 election, including potential run-offs, would typically see the winner determined and called by news sources (Market A's primary resolution method) well before Market B's 'before Jan 2027' deadline. Assuming standard political definitions and avoiding pedantic edge cases, the conditions and timeframes are virtually identical.
Found: Mar 27, 2026 9:24 PM
IPOs
Who will IPO before 2027?
[Anthropic]
+14.0%
Cost: $0.860
BUY [YES] on Polymarket ($0.42) AND BUY [NO] on Kalshi ($0.44)
Catalyst Intel:
Multiple news snippets indicate strong likelihood or confirmed plans for several high-profile companies to IPO before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is reported to be coming as early as October this year, with talks already underway with major banks. OpenAI is hinted at for a 2026 or early 2027 IPO, supported by SoftBank's $40B loan. Visma has delayed its IPO to next year (2025). These collectively represent a significant increase in the probability of multiple companies IPOing within the specified timeframe.
Found: Mar 28, 2026 1:19 AM
Legal Reasoning:
Both markets predict whether Anthropic will complete an Initial Public Offering (IPO) by the end of 2026. Market A explicitly states 'completes an Initial Public Offering (IPO)', while Market B states 'Anthropic confirms an IPO'. In the context of prediction markets, 'confirms an IPO' is understood to mean the IPO has completed or is definitively occurring. Therefore, if the IPO 'completes', Anthropic will 'confirm' it, and vice versa. The deadlines are identical ('by December 31, 2026, 11:59 PM ET' is equivalent to 'before Jan 1, 2027'). Market A's resolution sources ('official company announcements or credible news sources') include Anthropic's confirmation. There are no conflicting conditions, definitions, or tie-breakers.
Found: Mar 28, 2026 1:19 AM
AI regulation
AI regulation by 2027?
[By Jan 1, 2027]
+13.0%
Cost: $0.870
BUY [NO] on Polymarket ($0.61) AND BUY [YES] on Kalshi ($0.26) (SUBSET FREE-ROLL)
Catalyst Intel:
The news indicates that the application of key obligations of the EU AI Act, a significant international regulatory effort, could be delayed until 2027 or even 2028. While there are ongoing state-level legislative activities in the US and federal policy frameworks being discussed, these do not represent a massive, unified catalyst for comprehensive AI regulation to be fully implemented by 2027. The overall sentiment suggests challenges and potential delays in widespread regulatory adoption rather than an acceleration.
Found: Mar 28, 2026 5:00 AM
Legal Reasoning:
Market A's conditions are stricter and its deadline is earlier than Market B's. Market A requires a bill to include at least one of four specific provisions (prohibition, training restrictions, usage restrictions, human-in-the-loop) and be signed into law by December 31, 2026. Market B is broader, requiring any bill 'regulating AI' to become law by January 1, 2027. If Market A resolves to 'Yes', it means a specific type of AI regulation occurred by an earlier date, which would satisfy Market B's broader condition and later deadline. However, Market B could resolve to 'Yes' if a bill regulating AI (but not necessarily with Market A's specific provisions) becomes law on January 1, 2027, or if a bill regulating AI (but not with Market A's specific provisions) becomes law by December 31, 2026. Thus, if A happens, B must happen, but B can happen without A happening.
Found: Mar 28, 2026 5:00 AM
IPOs
Who will IPO before 2027?
[Vanta]
+12.0%
Cost: $0.880
BUY [NO] on Polymarket ($0.76) AND BUY [YES] on Kalshi ($0.12)
Catalyst Intel:
Multiple news snippets indicate strong likelihood and even confirmed filings for major IPOs before 2027. OpenAI is repeatedly linked to a 2026 IPO, supported by SoftBank's $40 billion loan. Anthropic is reported to be preparing for an IPO as early as October (this year), with significant valuation and talks with major banks. SK hynix confidentially filed for a U.S. IPO on April 30, 2025. SpaceX also has IPO buzz. These are significant developments for high-profile companies, indicating a strong wave of public offerings.
Found: Mar 28, 2026 3:42 AM
Legal Reasoning:
Both markets refer to an IPO by Vanta. Market A's deadline is "by December 31, 2026, 11:59 PM ET", which is identical to Market B's "before Jan 1, 2027". The resolution sources and conditions for an IPO confirmation are also functionally equivalent, with Market B's 'confirms an IPO' being covered by Market A's 'official company announcements or credible news sources'. The explicit 'No' conditions in Market A (merger, acquisition, ceases to exist) would implicitly prevent an IPO in Market B, meaning if Market A resolves 'No' for these reasons, Market B would also resolve 'No' because an IPO did not occur.
Found: Mar 28, 2026 3:42 AM
IPOs
Who will IPO before 2027?
[OpenAI]
+11.0%
Cost: $0.890
BUY [YES] on Polymarket ($0.4) AND BUY [NO] on Kalshi ($0.49)
Catalyst Intel:
Multiple news snippets indicate a strong likelihood of several high-profile companies IPOing before 2027. Kailera Therapeutics has already filed for a US IPO. Anthropic is reported to be coming as early as October (this year). Visma is delaying its IPO to next year (2025). SK hynix confidentially filed for a US IPO in April 2025. OpenAI is strongly signaled for a 2026 or early 2027 IPO, with SoftBank's $40B loan maturing in March 2027. SpaceX is also mentioned as 'coming soon'. This collective information points to a significant number of IPOs occurring within the specified timeframe.
Found: Mar 28, 2026 3:42 AM
Legal Reasoning:
Both markets refer to an IPO by OpenAI. Market A's deadline is "by December 31, 2026, 11:59 PM ET", which is functionally identical to Market B's "before Jan 1, 2027". Market A's definition of an IPO ("first sale of stock...to the public on any recognized stock exchange") is a standard understanding of an IPO, and Market B's "confirms an IPO" would rely on the same event. Market A's negative conditions (merger, acquisition, cessation of existence) are implicit in Market B as well; if OpenAI doesn't exist, it can't IPO. There are no material differences in conditions or timeframes that would lead to divergent resolutions.
Found: Mar 28, 2026 3:42 AM
IPOs
Who will IPO before 2027?
[Deel]
+11.0%
Cost: $0.890
BUY [NO] on Polymarket ($0.67) AND BUY [YES] on Kalshi ($0.22)
Catalyst Intel:
Multiple companies, including Kailera Therapeutics, Anthropic, OpenAI, Visma AS, and SpaceX, show strong indications or have already filed for an IPO before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is reported to be coming as early as October. OpenAI is hinted for a 2026 or early 2027 IPO. Visma AS is delaying its IPO to next year (2025). SpaceX is also mentioned as 'coming soon'. These events collectively represent a significant increase in the likelihood of companies IPOing before 2027.
Found: Mar 28, 2026 1:19 AM
Legal Reasoning:
Both markets resolve to 'Yes' if Deel completes an Initial Public Offering (IPO) by December 31, 2026. Market A specifies 'by December 31, 2026, 11:59 PM ET', while Market B states 'before Jan 1, 2027', which is the exact same timeframe. The resolution sources and definitions of an IPO are also consistent across both markets. If an IPO occurs, both will resolve 'Yes'; if not, both will resolve 'No'.
Found: Mar 28, 2026 1:19 AM
IPOs
Who will IPO before 2027?
[Discord]
+8.3%
Cost: $0.917
BUY [NO] on Polymarket ($0.287) AND BUY [YES] on Kalshi ($0.63)
Catalyst Intel:
Multiple news reports indicate SpaceX is preparing for a massive IPO, with some suggesting a filing 'as soon as this week' and a planned raise for 'June 2026.' This strongly suggests SpaceX will IPO before 2027, serving as a significant catalyst for the market.
Found: Mar 26, 2026 11:42 PM
Legal Reasoning:
Both markets require Discord to complete an Initial Public Offering (IPO) by the same deadline (December 31, 2026, which is equivalent to 'before Jan 1, 2027'). While Market A specifies 'official company announcements or credible news sources' for confirmation and Market B specifies 'Discord confirms an IPO', in the real world, an IPO confirmed by credible sources would inherently involve confirmation from the company itself (e.g., through official filings or announcements). Therefore, the conditions for a 'Yes' resolution are virtually identical, and either trade direction is safe.
Found: Mar 26, 2026 11:42 PM
OpenAI IPO timing.
When will OpenAI IPO?
[Before Jan 1, 2027]
+8.0%
Cost: $0.920
BUY [YES] on Polymarket ($0.44) AND BUY [NO] on Kalshi ($0.48)
Catalyst Intel:
Multiple news snippets indicate OpenAI is actively preparing for an IPO. Specifically, 'OpenAI Cleans House Ahead of IPO' suggests strategic streamlining for a public offering. Furthermore, the 'OpenAI ads pilot tops $100 million in annualized revenue in under 2 months' demonstrates significant, rapid financial growth in a high-margin business, which is highly attractive to potential IPO investors and a key step in 'sprucing up their financials ahead of mega-IPOs'. These actions and financial successes are strong indicators that an IPO is on the horizon and likely to occur sooner rather than later.
Found: Mar 27, 2026 8:06 AM
Legal Reasoning:
Both markets are tracking the same event: OpenAI completing an Initial Public Offering (IPO) before January 1, 2027. Market A's definition of an IPO and resolution sources align perfectly with the natural interpretation of Market B's conditions. The specific clause in Market A regarding acquisition by an already public company explicitly states a scenario that would implicitly lead to a 'No' resolution in Market B, as OpenAI itself would not have performed an IPO. Therefore, the conditions and outcomes are virtually identical.
Found: Mar 27, 2026 8:06 AM
Annual GDP
GDP growth in 2026?
[0.0 or below]
+6.1%
Cost: $0.939
BUY [NO] on Polymarket ($0.859) AND BUY [YES] on Kalshi ($0.08)
Catalyst Intel:
The news presents a mixed and sometimes conflicting picture regarding 2026 GDP growth forecasts across different regions. While S&P Global has revised India's FY26 growth forecast upwards to 7.6%, Goldman Sachs has simultaneously lowered India's 2026 forecast to 5.9%. Additionally, forecasts for countries like Sweden and Australia have been downgraded, often citing geopolitical conflicts. There is no clear, widespread, and unified shift in expectations that would constitute a massive catalyst for overall GDP growth in 2026.
Found: Mar 25, 2026 9:12 AM
Legal Reasoning:
Market A specifies the exact data source and methodology (BEA Advance Estimate for Q4 2026, seasonally adjusted and annualized GDP growth rate for full year 2026) for the condition 'GDP growth in 2026 below 0.0'. Market B uses a more general phrasing 'GDP growth in 2026 below 0.0'. Assuming standard definitions for economic data, Market B implicitly refers to the same official metric specified by Market A. Therefore, the conditions and resolution criteria are virtually identical.
Found: Mar 25, 2026 9:12 AM
Who will leave the Trump administration
Will Robert F. Kennedy Jr. leaves HHS Secretary in before 2027?
[:: HHS Secretary]
+6.0%
Cost: $0.940
BUY [YES] on Polymarket ($0.21) AND BUY [NO] on Kalshi ($0.73) (SUBSET FREE-ROLL)
Catalyst Intel:
Robert F. Kennedy Jr. is facing intense criticism as HHS Secretary for policies that critics claim endanger public health, risk the resurgence of deadly diseases, and could lead vaccine manufacturers to leave the U.S. market. Furthermore, a close ally indicates his 'Make America Healthy Again' movement is being 'sidelined' by the White House on vaccine policy, suggesting significant internal friction. These severe criticisms and policy conflicts create substantial pressure that could lead to his departure from the HHS Secretary role before 2027.
Found: Mar 28, 2026 12:00 AM
Legal Reasoning:
Market B requires Robert F. Kennedy Jr. to leave the specific role of HHS Secretary. Market A is broader, requiring him to leave any role within the Trump Administration. If he leaves as HHS Secretary, he necessarily leaves the Trump Administration. However, he could leave the Trump Administration from a different role (e.g., as an Ambassador or White House staffer), in which case Market A would resolve 'Yes' but Market B would resolve 'No'. The timeframes for both markets are identical ('before 2027' vs. 'by December 31, 2026'). Therefore, Market B's conditions are stricter and a subset of Market A's.
Found: Mar 28, 2026 12:00 AM
IPOs
Who will IPO before 2027?
[Rippling]
+6.0%
Cost: $0.940
BUY [NO] on Polymarket ($0.85) AND BUY [YES] on Kalshi ($0.09)
Catalyst Intel:
The news indicates multiple high-profile companies are either filing for an IPO, planning one as early as October, or are strongly rumored to go public well before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is expected to IPO as early as October. OpenAI is strongly linked to a 2026 or early 2027 IPO, with SoftBank's $40B loan pointing to a 2026 listing. Visma has delayed its IPO to next year (2025), still before 2027. SpaceX also has 'IPO buzz' and is mentioned as 'coming soon'. This collective information points to a significant number of IPOs occurring before the 2027 deadline.
Found: Mar 28, 2026 1:19 AM
Legal Reasoning:
Both markets resolve to 'Yes' if Rippling completes an IPO by the end of December 31, 2026. Market A specifies the deadline as 'December 31, 2026, 11:59 PM ET', while Market B states 'before Jan 1, 2027', which is functionally equivalent. The definition of IPO and the implicit confirmation mechanisms are also aligned, avoiding any conflicts or subset relationships for practical resolution. The 'No' conditions in Market A (merger, acquisition, cessation) are implicit outcomes for Market B as well, as these events would preclude Rippling from confirming an IPO.